ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
Tevogen Bio Holdings Inc

Tevogen Bio Holdings Inc (TVGN)

1.38
0.03
(2.22%)
마감 24 1월 6:00AM
1.38
0.00
(0.00%)
시간외 거래: 8:13AM

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
1.38
매수가
1.38
매도가
1.39
거래량
827,397
1.32 일간 변동폭 1.42
0.2556 52주 범위 21.09
market_cap
전일 종가
1.35
개장가
1.33
최근 거래 시간
30
@
1.385
마지막 거래 시간
재정 규모
US$ 1,148,846
VWAP
1.3885
평균 볼륨(3m)
2,631,048
발행 주식
175,051,247
배당수익률
-
주가수익률
-11,275.00
주당순이익(EPS)
-0
매출
-
순이익
-67k

Tevogen Bio Holdings Inc 정보

Tevogen Bio is a leading NextGen clinical-stage specialty immunotherapy Biotech developing off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Tevogen Bio is a leading NextGen clinical-stage specialty immunotherapy Biotech developing off-the-shelf precision T cell therapeutics in virology, oncology, and neurology.

섹터
Biological Pds,ex Diagnstics
산업
Blank Checks
웹사이트
본부
Wilmington, Delaware, USA
설립됨
2024
Tevogen Bio Holdings Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker TVGN. The last closing price for Tevogen Bio was US$1.35. Over the last year, Tevogen Bio shares have traded in a share price range of US$ 0.2556 to US$ 21.09.

Tevogen Bio currently has 175,051,247 shares in issue. The market capitalisation of Tevogen Bio is US$236.32 million. Tevogen Bio has a price to earnings ratio (PE ratio) of -11275.00.

TVGN 최신 뉴스

Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference

WARREN, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare Conference

The JPM Healthcare Conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies...

Tevogen Bio to Host Panel "AI In Biopharma: Next Frontier of Medical Innovation" During the 43rd Annual J.P. Morgan Healthcare Conference

WARREN, N.J., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth Agenda

WARREN, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio to Host Panel “Pioneering the Economics of Health: Balancing Access and Outcomes” During the 43rd Annual J.P. Morgan Healthcare Conference

WARREN, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare Conference

WARREN, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Dr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of Fame

WARREN, N.J., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Dr. Ryan Saadi, CEO of Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech...

Tevogen Bio Prepares Organizational Readiness to Support Company’s Growth Strategy

WARREN, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value

WARREN, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model

Improved operating performance by reducing net loss by $52.5 million; reported net loss of $4.3 million and $56.8 million for the nine months ended September 30, for 2024 and 2023...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.096.976744186051.291.40261.2057779781.30114284CS
40.2926.60550458721.091.570.989114920901.26588007CS
12-1.14-45.23809523812.522.63530.856526310481.4348761CS
260.613279.96870109550.76683.090.255686026651.54184764CS
52-2.72-66.34146341464.121.090.255649800601.5526354CS
156-2.72-66.34146341464.121.090.255649800601.5526354CS
260-2.72-66.34146341464.121.090.255649800601.5526354CS

TVGN - Frequently Asked Questions (FAQ)

What is the current Tevogen Bio share price?
The current share price of Tevogen Bio is US$ 1.38
How many Tevogen Bio shares are in issue?
Tevogen Bio has 175,051,247 shares in issue
What is the market cap of Tevogen Bio?
The market capitalisation of Tevogen Bio is USD 236.32M
What is the 1 year trading range for Tevogen Bio share price?
Tevogen Bio has traded in the range of US$ 0.2556 to US$ 21.09 during the past year
What is the PE ratio of Tevogen Bio?
The price to earnings ratio of Tevogen Bio is -11.28k
What is the reporting currency for Tevogen Bio?
Tevogen Bio reports financial results in USD
What is the latest annual profit for Tevogen Bio?
The latest annual profit of Tevogen Bio is USD -67k
What is the registered address of Tevogen Bio?
The registered address for Tevogen Bio is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Tevogen Bio website address?
The website address for Tevogen Bio is www.tevogen.com/
Which industry sector does Tevogen Bio operate in?
Tevogen Bio operates in the BLANK CHECKS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
DWTXDogwood Therapeutics Inc
US$ 13.2484
(373.16%)
103.21M
DGNXDiginex Ltd
US$ 12.75
(70.00%)
9.74M
RNAZTransCode Therapeutics Inc
US$ 5.61
(60.74%)
10.9M
EVAXEvaxion Biotech AS
US$ 3.76
(57.98%)
4.02M
MCTRCTRL Group Ltd
US$ 6.77
(56.35%)
8.84M
CHSNChanson International Holding
US$ 0.83352
(-86.77%)
21.85M
ICONIcon Energy Corporation
US$ 0.5348
(-59.18%)
15.88M
JUNSJupiter Neurosciences Inc
US$ 1.50
(-58.10%)
11.08M
BACKIMAC Holdings Inc
US$ 0.78
(-42.01%)
479.52k
DXSTDecent Holding Inc
US$ 2.50
(-38.42%)
11.55M
HEPAHepion Pharmaceuticals Inc
US$ 0.203
(50.37%)
538.53M
NVDANVIDIA Corporation
US$ 147.22
(0.10%)
155.52M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.33095
(3.75%)
153.25M
RIMEAlgorhythm Holdings Inc
US$ 0.0338
(1.81%)
137.6M
RGTIRigetti Computing Inc
US$ 13.465
(-3.20%)
133.14M

TVGN Discussion

게시물 보기
glenn1919 glenn1919 6 일 전
TVGN....................................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 2 주 전
TVGN.................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 주 전
TVGN....................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 1 월 전
TVGN...........................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
👍️0
Joe DiMaggio Joe DiMaggio 2 월 전
Buyback is on
👍️0
oleskool oleskool 2 월 전
can this hit 2$ , gut says not gonna happen
👍️0
tw0122 tw0122 2 월 전
See $4 zone ($4.20$4.54) as resistance now with the news eliminating debt and liabilities. Moves up slowly..
Tevogen reiterated its confidence in its financial stability, confirming sufficient available capital to fund operations for at least the next 33 months, supported by a loan agreement, which Tevogen entered into in June. Additionally, Tevogen eliminated almost all of its liabilities which were $99.9 million as reported at December 31, 2023 and now are $10.5 million as reported at September 30, 2024.





Tevogen’s internally developed intellectual property and product assets, valued internally at $10 billion+ using discounted cash flow models, are not reflected on the balance sheet. Due to US GAAP accounting rules, the company was unable to report the fair market value of its assets, including proprietary immunotherapy technologies and cutting-edge artificial intelligence platforms. The company believes that the inclusion of Tevogen’s IP assets on its balance sheet would significantly enhance its enterprise value



Commenting on the company’s performance and unique ownership structure, Dr. Saadi concluded, “Tevogen’s leadership stands apart in the biotech sector, with approximately 78% of equity retained by our officers, an extraordinary figure compared to the industry average of just 4%. In addition to our officers, our key employees have also been granted substantial restricted stock units in the company, reflecting our belief that our employees should also be owners of our success.”





👍 1 🚀 1
glenn1919 glenn1919 2 월 전
TVGN.........................................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
👍 1 🔥 1
glenn1919 glenn1919 2 월 전
TVGN..........................................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
👍️0
BurgerKing82 BurgerKing82 2 월 전
Looks interesting
👍️0
glenn1919 glenn1919 3 월 전
TVGN..................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
👍️ 1
tw0122 tw0122 3 월 전
$1.32 + 10% .. WARREN, N.J., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, nears finalization of agreement with CD8 Technology for a turn-key facility intended to support both pre-clinical research and GMP manufacturing capabilities, staffed by Tevogen.
👍️ 1
OffTheGrid OffTheGrid 3 월 전
Adding 
👍️0
HoldEm777 HoldEm777 3 월 전
https://www.stocktitan.net/news/TVGNW/tevogen-bio-expands-on-microsoft-partnership-to-integrate-machine-zepglnzxz4n7.html
👍️0
BardRaider17 BardRaider17 3 월 전
Yes sir
👍️0
getitrit getitrit 3 월 전
Is it true they are partners with Microsoft?
👍️0
BardRaider17 BardRaider17 3 월 전
I think I messed up. I'm sitting on 555 @ average 2.58 I really did not want to be stuck in that overnight. Thoughts?
👍️0
tw0122 tw0122 3 월 전
Flip out some $2.60s 
👍️ 1
tw0122 tw0122 3 월 전
Back in $2.20s for a flip maybe quick hopefully longer 
👍️ 1
tw0122 tw0122 3 월 전
Not much pumped some premarket so always careful have to see if $2.29- $2.47 zone holds afee profit taking then will add some perhaps 
👍️0
BardRaider17 BardRaider17 3 월 전
Can you explain what that means for me? Im new TY
👍️0
tw0122 tw0122 3 월 전
TVGN 3.20 trading float about 21m about 15m traded so far 
👍️0
tw0122 tw0122 3 월 전
TVGN $4s coming will trade whole float by 930am
👍️0
tw0122 tw0122 3 월 전
Tevogen Bio To Provide Timelines Associated with Recently Announced Revenue Forecast and Updates on Operational Readiness This WeekOctober 22 2024 - 2:30PM


Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, plans to provide further updates on the previously announced revenue forecast for Tevogen Oncology and Tevogen Specialty Care therapeutic areas by the end of this week. The revenue forecast for the two therapeutic areas is approximately $1 billion each in their respective launch years. The 5-year combined estimate for the two therapeutic areas is between $28 billion and $36 billion.Tevogen Bio also plans to update shareholders on Tevogen AI, its proprietary artificial intelligence effort, designed to advance a mission to lower the total cost of drug development, expedite drug discovery, and deliver life-changing therapies to large patient populations. In addition, Tevogen Bio will provide an update on clinical and commercial manufacturing.
👍️0
tw0122 tw0122 3 월 전
TVGN 3.75 -3.88 zone up there and then $4.27 on high side in the 2.62-3.40 zone for now
👍️0
glenn1919 glenn1919 3 월 전
tvgn............................https://stockcharts.com/h-sc/ui?s=tvgn&p=W&b=5&g=0&id=p86431144783
👍️0
dinogreeves dinogreeves 3 월 전
Actually buying more tomorrow, price targets changed 16-18 dollars by year end.
👍️0
eur06 eur06 3 월 전
In less than 2 years CVNA went absolutely nuts wow!!!
TVGN
👍️0
da_stock_analyst da_stock_analyst 3 월 전
#TVGN 🔥 70% short interest & $TVGN squeezing! watch this week!
👍️0
frans frans 3 월 전
thanks
👍️0
dinogreeves dinogreeves 3 월 전
SAVE could do similar pattern as CVNA did.
👍️0
dinogreeves dinogreeves 3 월 전
For me personally not going to wait 10-12. I will sell at $6.00
👍️0
frans frans 3 월 전
SAVE - when to 10 - 12 $ and who is selling all those shares?
👍️0
dinogreeves dinogreeves 3 월 전
SAVE will run big 10-12 dollars
👍️0
eur06 eur06 3 월 전
Wow uavs!!!!
save still ok ?
TVGN
👍️0
dinogreeves dinogreeves 3 월 전
It was a great setup, I was looking for the Microsoft deal to come through and it did. Made my move on SAVE and UAVS.
👍️0
dinogreeves dinogreeves 3 월 전
No loaded 4000 shares this morning, it should run to 7-8 dollars but it will get to 10-12 dollar range. Float is next to nothing. They have contracts with the French Army and the United Nations. Severly undervalued.
👍️0
eur06 eur06 3 월 전
Wow that chart looks hot hot hot..lol
Just got some…waiting for updates?
TVGN
👍️0
tw0122 tw0122 3 월 전
TVGN 2.90 time to flip this champ again. Happy trading 
👍️0
dinogreeves dinogreeves 3 월 전
Buy UAVS too.
👍️0
eur06 eur06 3 월 전
Great call dino…we’re making $$$ so far!!!!
OSS
👍️0
tw0122 tw0122 3 월 전
MSFT deal $2.50 +50%
👍️0
TimeFades TimeFades 3 월 전
Moon soon. A lot of headwinds
👍️0
JUST 10-11-12 JUST 10-11-12 3 월 전
This should go much higher than five: "..... Dr. Saadi added, "I was pleased that Tevogen was able to provide updates on the Company, including our pipeline, our $1 billion launch year oncology guidance, and I expect to share more details on further progress in the coming days."....."
👍️0
JUST 10-11-12 JUST 10-11-12 3 월 전
Got it
👍️0
JUST 10-11-12 JUST 10-11-12 3 월 전
Why can I not uy Tvgn?
👍️0
knrorrel knrorrel 3 월 전
SOUNDS AWESOME $TVGN IS READY
👍️0
glenn1919 glenn1919 3 월 전
TVGN.............................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
👍️0
SolarRevolution SolarRevolution 3 월 전
Showtime! Momentum , great news, and more news this week!

$$$

:)

Let’s do this !
👍️0
StemCelzRock StemCelzRock 3 월 전
TVGN heading to $5.00 this week, don’t miss it. Nice PR!!!!!!!! Boom time.
👍️0

최근 히스토리

Delayed Upgrade Clock